Result: Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2023

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

Nature cancer. - 4 (2023) , 96-107, ISSN: 2662-1347

*DOI*:

10.1038/s43018-022-00503-w

*Result*: Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial